BREAKING
Earnings Summary: A snapshot of Duke Energy’s Q4 2025 report 20 hours ago Fiserv (FISV) Earnings: 4Q25 Key Numbers 22 hours ago CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline 22 hours ago Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 1 day ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 1 day ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 2 days ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 2 days ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 2 days ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 2 days ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 2 days ago Earnings Summary: A snapshot of Duke Energy’s Q4 2025 report 20 hours ago Fiserv (FISV) Earnings: 4Q25 Key Numbers 22 hours ago CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline 22 hours ago Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 1 day ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 1 day ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 2 days ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 2 days ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 2 days ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 2 days ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 2 days ago
ADVERTISEMENT
AlphaGraphs

DHR Earnings: Danaher Corporation Q3 2023 sales and profit decline

Technology company Danaher Corporation (NYSE: DHR) Tuesday announced financial results for the third quarter of 2023, reporting lower sales and net profit. Third-quarter net income was $1.13 billion, or $1.51 per share, compared to $1.55 billion or $2.10 per share in the same period of last year. Adjusted earnings dropped 21% annually to $2.02 per share. […]

October 24, 2023 1 min read

Technology company Danaher Corporation (NYSE: DHR) Tuesday announced financial results for the third quarter of 2023, reporting lower sales and net profit.

Danaher Corporation Q3 2023 earnings infographic

Third-quarter net income was $1.13 billion, or $1.51 per share, compared to $1.55 billion or $2.10 per share in the same period of last year. Adjusted earnings dropped 21% annually to $2.02 per share.

The weak earnings performance reflects an 11% decrease in third-quarter revenues to $6.87 billion, mainly due to lower sales in the Diagnostics and Biotechnology segments.

Prior Performance

  • Danaher Corporation Q4 2022 earnings infographic

ADVERTISEMENT
ADVERTISEMENT